Gdp Pharma Limited
Summary
Gdp Pharma Limited was set up on Thursday the 25th of August 2011. Their current partial address is Dublin, and the company status is Normal. The company's current director has been the director of 25 other Irish companies; 13 of which are now closed. Gdp Pharma Limited has 1 shareholder.
Credit Score
- Latest Credit Movement:
- Date of Last Movement:19/12/2024
- Latest Accounts Filed:25/11/2024
- Report Based On Accounts:31/12/2023
- Next Set of Accounts Due:30/09/2025
- Overdue:No
Credit Report
- Credit Report & Financials
- Company Printout Report
- Directors & Owners Report
- Bad Debt Judgments Report
- Mortgages Report
€9
Company Vitals
- Company Name:Gdp Pharma Limited
- Time in Business:13 Years
- Company Number:502742
- Company Size:Small Company
- Current Status:NORMAL
- Website:gdppharma.ie
- Phone:+353 (0)1 802 1895
- Principal Activity:[51.46] Wholesale of Pharmaceutical Goods
- May Trade As:Gdp Pharma Ltd
- Disclaimer: Other Details
- Please note the 'other details' displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us
- Largest Company Shareholder:
- Registered Address:Unit 16,
Northern Cross Business Park North Road,
Finglas Dublin 11,
Finglas, Dublin, Ireland
€3
Directors
Purchase either the Standard Company Report or a Credit Report to view details on the directors of this company.
Documents
| Document | Pages | Effective | Received | Buy |
|---|---|---|---|---|
| FINANCIAL STATEMENT | 9 | 30/09/2024 | 25/11/2024 | |
| Form B1C - Annual Return General | 4 | 30/09/2024 | 25/11/2024 | |
| OTHER DIRECTORSHIP LIST | 1 | 30/09/2024 | 25/11/2024 | |
| B83 ALTERATION OF FINANCIAL YEAR END DATE | 2 | 28/11/2023 | 28/11/2023 | |
| Form B1C - Annual Return General | 4 | 30/09/2023 | 27/11/2023 | |
| Constitution | 13 | 16/08/2016 | 25/08/2016 | |
| Migrated Certificate | 1 | 25/08/2011 | 22/08/2011 |